Leveraging mRNA technology to accelerate HIV vaccine development

Vaccine Insights 2023; 2(3), 87–92

DOI: 10.18609/vac.2023.016

Published: 5 April 2023
Mark Feinberg

Charlotte Barker, Editor, BioInsights, speaks to (pictured) Mark Feinberg, President & CEO, IAVI (formerly known as the International AIDS Vaccine Initiative) to explore how the nonprofit is bringing the latest advances in vaccine science to the fight against HIV and other diseases disproportionately affecting people living in low-income countries.